nef gene leads to an attenuated virus phenotype in vivo. We have previously shown that these viruses induce a potent cellular immune response in macaques. To extend these studies, we established virus-specific short-term T-cell lines from four rhesus macaques infected with a nef deletion mutant of SIV. These T-cell lines proliferated upon restimulation with whole SIV or SIV gp140 antigen in vitro. The proliferating cells were characterized as CD4 M helper T-cells (TH) and their antigen recognition was MHC class II DR-restricted. After antigenic stimulation, they transcribed mRNA for various TH1-and TH2-like cytokines. Using these SIV-specific cell
Introduction
Since the discovery of human immunodeficiency virus (HIV) as the causal agent of AIDS, the infection of macaques with simian immunodeficiency viruses (SIV) has been the main approach to study vaccination. Although some success has been achieved in this model using viral antigens as vaccines (Hu et al., 1992 ; Lu$ ke et al., 1995) , the most promising results have come from experiments with attenuated SIV (Marthas et al., 1990 ; Daniel et al., 1992 ; Stahl-Hennig et al., 1996) . Such viruses have been experimentally attenuated by the deletion of regulatory genes. Deletion of the SIV nef gene (SIV∆nef) leads to an attenuated phenotype of the virus characterized by reduced replicative ability in macaques (Kestler et al., 1991) . Although a few cases of SIV∆nef-induced immunodeficiency have been found (Cohen, 1997) , attenuated SIV does not usually cause disease but induces a potent antiviral immune response. To understand the mechanism of protection, the 9204. e-mail udittmer!atlas.niaid.nih.gov lines, a variety of helper T-cell epitopes in the SIV Env protein were determined with overlapping peptides. TH epitopes were identified throughout the whole SIV Env including both constant and variable regions. Although the recognition of TH epitopes was heterogeneous among different animals, five more broadly reactive T-cell epitopes were identified. As expected, recognition was associated with the MHC class II DRB background of the animals. This is the first report on helper T-cell epitopes in SIV-infected monkeys. Such studies should be of considerable significance for AIDS/ vaccine research.
immune response of macaques infected with attenuated SIV has to be investigated in detail. We and others have previously reported on the SIV-specific helper T-cell (TH) and cytotoxic T-cell (CTL) responses of animals infected with SIV∆nef (Dittmer et al., 1995 b ; Gallimore et al., 1995 ; Gundlach et al., 1997) . The identification of T-cell epitopes on SIV proteins is a second important step towards the understanding of SIV immune recognition. Several groups have previously characterized SIV-specific TH epitopes from animals immunized with different prototype vaccines based on the core (Mills et al., 1991 ; Lehner et al., 1993 ; Brookes et al., 1995) or envelope protein (Jones et al., 1992 ; Voss et al., 1993 b) of SIV. However, since pathogenic SIV leads to early TH-dysfunction (Voss et al., 1993 a ; Dittmer et al., 1994 ) TH epitopes have not been described in infected animals until now. The infection of macaques with attenuated SIV provides a unique model to determine TH-cell specificities in infected animals. We have used short-term T-cell lines from four SIV∆nef-infected rhesus macaques to determine TH epitopes in the Env protein of SIV. Five broadly reactive epitopes were identified which seem to be associated with the major histocompatibility complex (MHC) class II DRB background of the animals. . A proliferation assay with STCL from 10 weeks post-SIV∆NU infection revealed similar results. The STLC from four uninfected controls and one SIV-infected animal were generated as described for the SIV∆NU-infected macaques. 
Methods
Animals and viruses. The rhesus macaques (Macaca mulatta) used for this study were housed at the German Primate Center in Go$ ttingen, Germany. Handling of the monkeys and collection of specimens were performed according to institutional guidelines as described previously (Stahl-Hennig et al., 1990) . The four rhesus monkeys, Mm 7755, 7756, 7761 and 7763, were infected intravenously with 300 TCID &! of the apathogenic SIV∆NU containing deletions of 513 bp in the nef gene (described in Gundlach et al., 1997) . Virus replication was detected in all animals but they did not develop any signs of an immunodeficiency over 70 weeks post-infection (Gundlach et al., 1997 ; C. Stahl-Hennig, unpublished data) . During the course of infection with SIV∆NU, all four animals developed virus-specific TH responses (Gundlach et al., 1997) . This enabled us to use peripheral blood mononuclear cells (PBMC) from these animals to establish SIV-specific T-cell lines and to study T-cell specificity.
T-cell proliferation assay and epitope mapping. At weeks 10 and 34 after infection with SIV∆NU, we generated SIV-specific shortterm cell lines (STCL) from PBMC of the four animals essentially as described (Lehner et al., 1993) . Briefly, 3i10' PBMC\ml were cultured in RPMI 1640 cell growth medium (1 : 1 ; supplemented with 10 % FCS) for 14 days in the presence of 2n5 µg\ml purified inactivated SIV antigen (Dittmer et al., 1994) . In addition, STCL from four uninfected controls and one animal infected with pathogenic SIV were established. After 14 days, 0n5 or 2n5 µg\ml inactivated SIV or 2n5 or 5 µg\ml recombinant SIV gp140 (Program EVA) were used as antigen to restimulate 2i10% T-cells in the presence of 1i10& autologous irradiated PBMC (40 Gy) as antigen-presenting cells (APC). The 5 day proliferation assays were performed in triplicate using Cell Growth Medium (Vitromex) supplemented with 1 % human AB serum. [$H]Thymidine (0n5 µCi per well) was present during the last 6 h of cultivation, and the incorporated radioactivity was determined in a β-counter. For the epitope mapping, 2i10% STCL were cultured for 5 days in duplicate with 10 µg\ml SIVmac251\32H Env peptides covering the whole SIV Env protein (Program EVA ; McBride et al., 1993) and 1i10& irradiated autologous PBMC. The 46 peptides used were 20-mer synthetic peptides overlapping by 10 amino acids. Two unrelated HIV-1 Env peptides (no. 10 and no. 30 ; Program EVA) served as control antigens. Proliferative responses were considered as positive if the mean counts per minute (c.p.m.) of cultures containing antigen was greater than twice the background (mean c.p.m. without antigen ; .
Phenotypic characterization of T-cells.
To determine the phenotype of the proliferating cells, CD4 subsets were isolated with immunomagnetic beads from STCL generated 34 weeks after SIV∆NU infection as described (Voss et al., 1993 b) . The remaining cells, together with the cells bound to the beads, were then restimulated with 2n5 µg\ml inactivated SIV antigen in the presence of autologous irradiated PBMC (40 Gy) as APC.
The MHC restriction of the antigen presentation for the proliferating cells was assessed by adding monoclonal antibodies (1 : 1000) specific for MHC class I (W6\32) or class II DR (Q513) molecules as described (Voss et al., 1993 b) . The proliferation assay was then performed for both as described above.
To determine which T-cell subsets were present in the STLC after 14 days of culture, we characterized the phenotype of STCL cells by flow BIAC SIV Env-specific helper T-cell epitopes SIV Env-specific helper T-cell epitopes cytometry using labelled CD2-(55.2 ; Becton Dickinson), CD4-(OKT4 ; Orthomune) and CD8-specific (3B5 ; Medac) antibodies (Stahl-Hennig et al., 1990) .
Cytokine transcription. Cytokine transcription was measured after SIV-specific restimulation of STCL in vitro using a semiquantitative RT-PCR (Spring et al., 1997) . The PCR was optimized for every cytokine transcript to generate signals that could be evaluated within a linear range of the PCR process. The resulting cycle numbers were : 34 for IL-2, IL-4 and INF-γ ; 32 for IL-6 and IL-10 ; 30 for β-actin. The intensity of the resulting band was quantified with the Gelprint documentation system (MWG-Biotech) for each cell line and compared with the intensity of the respecting β-actin band (housekeeping gene).
MHC background of the rhesus macaques. The MHC class II DRB background of the rhesus macaques (Mamu-DRB) was investigated by gel electrophoretic analysis. The second exon of the Mamu-DRB genes was amplified by PCR as described (Slierendregt et al., 1994) . The PCR products were separated on a precast polyacrylamide gel according to their GC nucleic acid content (GenGel Excel ; 12 % polyacrylamide) using the GenPhor-System (20 mA, 5 h ; Pharmacia). Bands were then visualized by standard silver staining.
Results and Discussion
At 10 and 34 weeks after SIV∆NU-infection of four rhesus macaques, STLC were established to determine SIV-specific Tcell epitopes. After 2 weeks of virus-specific stimulation, the STCL showed a proliferative response after restimulation with subsets were isolated with immunomagnetic beads from STCL of animal 7756 generated 34 weeks after SIV∆NU infection, as described previously (Voss et al., 1993 b) . The purity of CD4 cell populations were greater than 95 % as determined by flow cytometry. All cell subsets were then restimulated with 2n5 µg/ml inactivated SIV antigen in the presence of autologous irradiated APC. Irradiated APC and cultures without antigen (Medium) were used as controls. (b) STCL from animal 7755 generated 10 weeks after SIV∆NU infection were restimulated with 2n5 µg/ml inactivated SIV antigen and autologous APC in the presence of monoclonal antibodies specific for MHC class I (W6/32) or class II DR (Q513) molecules. Cultures without antibodies (STCL) or without antigen (Medium) served as controls. In both experiments [ 3 H]thymidine uptake was measured in c.p.m. Error bars represent standard deviation calculated by the formula σin-1. The horizontal line represents the experimental cut-off (2-fold greater than background).
purified SIV, as well as against the recombinant SIV gp140, that was greater than twice that of cultures without antigen (Table 1) . The SIV gp140-specific response was lower than the response to whole virus, possibly due to the antigen preparation or to specificities against other SIV antigens. Three out of four STCL from SIV∆NU-infected macaques developed SIV-specific proliferative responses 4-fold greater than background. The STCL from SIV∆NU-infected animals showed no reactivity against unrelated control antigens (Fig. 1) . In addition, none of the STCL from four uninfected controls or an animal infected with pathogenic SIV showed a SIV-specific proliferation (Table 1) . However, the STCL of all investigated animals responded (c.p.m. were 3n9-11n2-fold greater than background) after phytohaemagglutinin stimulation (1 %, v\v).
To determine which T-cell populations were proliferating in response to SIV antigen, we characterized the phenotype of STCL. Approximately 60 % of the cells from STCL were CD2 + lymphocytes. Up to 25 % CD4 + and 45 % CD8 + cells were detected in the STLC. However, the SIV-specific proliferation was exclusively linked to the CD4 + cells. CD4-expressing cells isolated from the STCL proliferated after restimulation with soluble SIV and APC, whereas CD4-depleted STCL did not respond. The CD4-cell reactivity could be blocked by an MHC class II DR-specific antibody (Fig. 1) . Therefore, the specifically proliferating T-cells were characterized as helper T-cells. SIV Env-specific helper T-cell epitopes SIV Env-specific helper T-cell epitopes Table 2 . Cytokine transcription of SIV-specific stimulated STCL from SIV∆nef-infected macaques
Cytokine transcription was measured in a semiquantitative RT-PCR (Spring et al., 1997) . The intensity of the resulting band compared with the intensity of the respective β-actin band of each cell type is indicated as follows : k, no PCR product visible ; j\k, only half of the samples showed a low intensity band ; j, the intensity of the band was lower than the intensity of the β-actin band but was visible for all samples ; jj, similar intensity of the cytokine and the β-actin band.
* STLC (2i10' cells) of SIV∆nef-infected macaques after restimulation with irradiated autologous PBMC (APC) presenting SIV antigen (n l 4). † Irradiated PBMC (APC) of SIV∆nef-infected macaques alone (n l 4). ‡ PBMC (2i10') isolated from naive macaques without any in vitro culture served as a control (n l 10).
To investigate the functional properties of the virus-specific STCL, we determined their cytokine transcription after in vitro restimulation with autologous APC and inactivated SIV antigen. We detected increased transcription of the cytokines IFN-γ and IL-2, -4 and -10 for all four virus-specific STCL in comparison to APC alone (Table 2 ). In addition, transcription of the same cytokines, except IL-2, was enhanced compared to unstimulated monkey PBMC. This implied that the SIVspecific proliferating TH consisted of both TH1-, TH2-and\or perhaps TH0-like T-cell populations.
Table 3. Sequence of SIV Env epitopes recognized by STCL from several SIV∆nef-infected animals
All peptides that were recognized by the STCL of at least two out of four animals are listed. The epitope in the C2 region seems to be in the overlapping region of peptides 25 and 26. The STCL from four uninfected control animals and one animal infected with pathogenic SIV did not recognize any of these peptides.
Region of
No. of animals Peptide no.
Amino acid sequence SIV Env responding   1  YCTQYVTVFYGVPAWRNATI  C1  2  4  TWGTTQCLPDNGDYSELALN  C1  3  7  TVTEQAIEDVWQLFETSIKP  C1  2  11  WGLTKSLTTTAPTAPTAASK  V1  2  25\  SCTRMMETQTSTWFGFNGTR  C2  26  STWFGFNGTRAENRTYIYWH  C2  3 After characterization of the SIV-specific STCL, the cell lines were used to determine TH-epitopes. Since the external glycoprotein of immunodeficiency viruses is the primary candidate for vaccine components, we determined the TH response against the SIV glycoprotein. For this purpose, we used synthetic peptides covering the extracellular region of the SIVmac251\32H Env protein. A large number of different peptides were recognized by STCL from the four SIV∆NU-infected animals (Fig. 2) . Thus, the recognition of SIV Env peptides by STCL from SIV∆NU-infected macaques showed a strong heterogeneity among different animals. However, five peptides were immunogenic for two or more of the animals ( Table 3) . None of these peptides were recognized by STCL generated from four uninfected controls or from one animal infected with pathogenic SIV (data not shown). Two of the TH epitopes found in SIV∆NU-infected monkeys (peptides 7 and 25) have also previously been described for macaques immunized with SIV Env protein vaccines (for review see Voss & Hunsmann, 1993 ; Mills & Jones, 1994) . In addition, some previously undescribed epitopes (peptides 1, 4 and 11) were identified. In some cases, STCL from SIV∆NU-infected animals recognized a pair of overlapping peptides, suggesting the presence of an epitope in the overlapping region (peptides 1\2, 25\26, 34\35, 43\44 ; Fig. 2 ). The two unrelated HIV-1 control peptides (Ca and Cb) were not immunogenic in any of our assays (Fig. 2) . Notably, TH epitopes were identified throughout the whole SIV Env protein including both constant and variable regions. The lower number of recognized peptides in the variable regions of Env might be due to amino acid changes in these regions during virus replication in vivo. However, no major differences in the TH response were found between two independent assays at week 10 and week 34 after infection (data not shown). Since the infecting SIV∆NU is derived from SIVmac239 (Regier et al., 1990) , whereas the peptides used for in vitro restimulation were synthesized according to the consensus sequence of SIVmac251\32H U. Dittmer and others U. Dittmer and others Fig. 3 . Electrophoretic analysis of MHC class II DRB alleles. The MHC class II DRB background of the rhesus macaques (Mamu-DRB) was investigated by gel electrophoretic analysis. The second exon of Mamu-DRB genes was amplified by PCR. The PCR products were then separated according to their GC nucleic acid content on a polyacrylamide gel. Bands were visualized by standard silver staining. The individual animals are indicated. (Cranage et al., 1990) , it might be that some TH epitopes have not been identified in our assay due to sequence variations. Interestingly, over 75 % of the TH epitopes were identified in regions that were genetically identical between the two closely related SIV isolates.
Since the proliferative activity in our assay was MHC class II DR-restricted, the heterogeneity of the TH recognition might be due to MHC class II DRB polymorphism of the animals. The MHC class II DRB locus (Mamu-DRB) is known to be highly polymorphic in rhesus macaques (Slierendregt et al., 1994) . Therefore, denatured Mamu-DRB PCR products were analysed by gel electrophoresis. This analysis revealed differences between the animals, except for no. 7761 and no. 7763 which showed a very similar pattern of Mamu-DRB genes (Fig. 3) . These findings were confirmed by sequence analysis of cloned PCR products (data not shown). Interestingly, the STCL of these two monkeys recognized three identical peptides. Furthermore, TH epitopes shared by other animals might also be associated with identical MHC class II genes. It has also been suggested that individual peptides may be recognized by T-cells from animals of more than one haplotype (Jones et al., 1992 ; Brookes et al., 1995) . Although an association between MHC genes and TH epitopes was found, the MHC restriction of the TH epitopes described was not defined in this study. Furthermore, other MHC class II genes beside those of the DR locus might have contributed to peptide recognition in our animals.
The demonstrated ability to elicit TH responses to diverse peptides in MHC-disparate animals by attenuated SIV suggests that a similar vaccine strategy might be successful against HIV in humans. Furthermore, identification of TH epitopes recognized by T-cells from animals of more than one MHC class II DR haplotype can be useful for different vaccine approaches. In this context, the TH response raised during infection of macaques with apathogenic SIV could be of great importance to understanding retroviral immunity.
